|
PMS2CL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.18793863634892E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.8238001653923E-10 |
| Normal-vs-Stage2 |
5.977800E-03 |
| Normal-vs-Stage3 |
2.779900E-03 |
| Normal-vs-Stage4 |
2.789800E-02 |
| Stage1-vs-Stage2 |
6.050200E-01 |
| Stage1-vs-Stage3 |
2.572200E-01 |
| Stage1-vs-Stage4 |
4.518200E-01 |
| Stage2-vs-Stage3 |
2.501600E-01 |
| Stage2-vs-Stage4 |
2.713200E-01 |
| Stage3-vs-Stage4 |
9.731800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.94209101525666E-14 |
| Normal-vs-AfricanAmerican |
1.74559999999158E-06 |
| Normal-vs-Asian |
2.662000E-01 |
| Caucasian-vs-AfricanAmerican |
8.003400E-01 |
| Caucasian-vs-Asian |
6.301600E-03 |
| AfricanAmerican-vs-Asian |
1.007900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.94166904776694E-12 |
| Normal-vs-Female |
7.95239996076447E-09 |
| Male-vs-Female |
3.168200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.62830000000658E-05 |
| Normal-vs-Extreme_Weight |
4.78920000324123E-08 |
| Normal-vs-Obese |
1.17199999705164E-08 |
| Normal-vs-Extreme_Obese |
4.392500E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.910200E-01 |
| Normal_Weight-vs-Obese |
7.826200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.496800E-01 |
| Extreme_Weight-vs-Obese |
7.350200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.982600E-01 |
| Obese-vs-Extreme_Obese |
6.854800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.374100E-04 |
| Normal-vs-Age(41-60Yrs) |
5.38458166943201E-14 |
| Normal-vs-Age(61-80Yrs) |
2.22840002006564E-09 |
| Normal-vs-Age(81-100Yrs) |
9.264300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.101600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.147400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.824200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.597990E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.384790E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.894800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.938060E-02 |
| Normal-VS-KIRP CIMP |
6.417600E-01 |
| Normal-VS-Unclassified PRCC |
5.53180000000264E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.22440000360768E-08 |
| Type1 PRCC-VS-KIRP CIMP |
3.66569999999955E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
7.977200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.188400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.119900E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.390200E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.780800E-04 |
| Normal-vs-N1 |
1.738950E-03 |
| Normal-vs-N2 |
2.052200E-01 |
| N0-vs-N1 |
8.964000E-01 |
| N0-vs-N2 |
6.447000E-01 |
| N1-vs-N2 |
6.531000E-01 |
|
|
